Key result
The role of inherited or acquired thrombophilia in IVF outcomes remains debated, and a standardized therapeutic approach for antithrombotic treatments in women with infertility is currently lacking.
Why the study?
The role of inherited and/or acquired thrombophilia remains debated and a univocal antithrombotic therapeutic approach is lacking in women undergoing IVF with embryo transfer.
Does antithrombotic treatment (aspirin or low-molecular-weight heparin) improve pregnancy outcomes or prevent thrombosis in women undergoing IVF with embryo transfer?
Does antithrombotic treatment (aspirin or low-molecular-weight heparin) improve pregnancy outcomes or prevent thrombosis in women undergoing IVF with embryo transfer?
Current evidence on the role of thrombophilia and the optimal use of thromboprophylaxis in women undergoing IVF remains inconclusive and highly variable across studies.
No takes yet. Share an insight, caveat, or question.
Supports caution against routine antithrombotics in IVF; leaves thrombophilia's role unresolved pending prospective trials.
Micco et al. (2020) conducted a review in Infertility requiring IVF with embryo transfer. Antithrombotic treatments (aspirin or low-molecular-weight heparin) was evaluated. The role of inherited or acquired thrombophilia in IVF outcomes remains debated, and a standardized therapeutic approach for antithrombotic treatments in women with infertility is currently lacking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: